热景生物：参股公司公开增肌靶点MSTN小核酸药物核心专利

Core Viewpoint - Recently, Beijing Yaojing Gene Technology Co., Ltd., a subsidiary of Hotgen Biotech (688068), was granted a patent by the National Intellectual Property Administration for "siRNA and its conjugates that inhibit MSTN gene expression and applications" [1] Group 1 - The patent provides a method to inhibit MSTN gene expression through siRNA molecules [1] - The innovation aims to offer new treatment options for diseases related to MSTN gene, including obesity [1]